nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—ALB—acquired immunodeficiency syndrome	0.265	1	CbGaD
Etodolac—UGT2B7—Zidovudine—acquired immunodeficiency syndrome	0.0818	0.158	CbGbCtD
Etodolac—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.079	0.153	CbGbCtD
Etodolac—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0599	0.116	CbGbCtD
Etodolac—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0315	0.0609	CbGbCtD
Etodolac—ALB—Saquinavir—acquired immunodeficiency syndrome	0.028	0.0541	CbGbCtD
Etodolac—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0268	0.0519	CbGbCtD
Etodolac—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0243	0.0471	CbGbCtD
Etodolac—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0234	0.0452	CbGbCtD
Etodolac—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.022	0.0425	CbGbCtD
Etodolac—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.022	0.0425	CbGbCtD
Etodolac—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0199	0.0385	CbGbCtD
Etodolac—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0199	0.0385	CbGbCtD
Etodolac—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0172	0.0332	CbGbCtD
Etodolac—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0167	0.0322	CbGbCtD
Etodolac—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0151	0.0292	CbGbCtD
Etodolac—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0151	0.0292	CbGbCtD
Etodolac—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0144	0.028	CbGbCtD
Etodolac—UGT1A10—digestive system—acquired immunodeficiency syndrome	0.00205	0.113	CbGeAlD
Etodolac—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.00145	0.0793	CbGeAlD
Etodolac—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.00103	0.0565	CbGeAlD
Etodolac—RXRA—nervous system—acquired immunodeficiency syndrome	0.000947	0.0519	CbGeAlD
Etodolac—RXRA—central nervous system—acquired immunodeficiency syndrome	0.000911	0.05	CbGeAlD
Etodolac—UGT2B7—digestive system—acquired immunodeficiency syndrome	0.00083	0.0455	CbGeAlD
Etodolac—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000793	0.0435	CbGeAlD
Etodolac—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000772	0.0423	CbGeAlD
Etodolac—PTGS2—endothelium—acquired immunodeficiency syndrome	0.000758	0.0416	CbGeAlD
Etodolac—RXRA—brain—acquired immunodeficiency syndrome	0.000724	0.0397	CbGeAlD
Etodolac—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000705	0.0386	CbGeAlD
Etodolac—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000673	0.0369	CbGeAlD
Etodolac—SLC22A6—brain—acquired immunodeficiency syndrome	0.000451	0.0247	CbGeAlD
Etodolac—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000339	0.0186	CbGeAlD
Etodolac—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000324	0.0177	CbGeAlD
Etodolac—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000297	0.0163	CbGeAlD
Etodolac—CYP2C9—blood—acquired immunodeficiency syndrome	0.000283	0.0155	CbGeAlD
Etodolac—ALB—brain—acquired immunodeficiency syndrome	0.000281	0.0154	CbGeAlD
Etodolac—ALB—lymph node—acquired immunodeficiency syndrome	0.000272	0.0149	CbGeAlD
Etodolac—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000271	0.0149	CbGeAlD
Etodolac—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000262	0.0144	CbGeAlD
Etodolac—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000259	0.0142	CbGeAlD
Etodolac—PTGS1—blood—acquired immunodeficiency syndrome	0.000258	0.0142	CbGeAlD
Etodolac—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000249	0.0136	CbGeAlD
Etodolac—PTGS2—blood—acquired immunodeficiency syndrome	0.000247	0.0135	CbGeAlD
Etodolac—PTGS1—vagina—acquired immunodeficiency syndrome	0.000239	0.0131	CbGeAlD
Etodolac—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000239	0.0131	CbGeAlD
Etodolac—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000238	0.013	CbGeAlD
Etodolac—PTGS2—vagina—acquired immunodeficiency syndrome	0.000229	0.0125	CbGeAlD
Etodolac—PTGS1—lung—acquired immunodeficiency syndrome	0.000226	0.0124	CbGeAlD
Etodolac—PTGS2—lung—acquired immunodeficiency syndrome	0.000216	0.0119	CbGeAlD
Etodolac—PTGS1—nervous system—acquired immunodeficiency syndrome	0.00021	0.0115	CbGeAlD
Etodolac—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000202	0.0111	CbGeAlD
Etodolac—PTGS2—nervous system—acquired immunodeficiency syndrome	0.0002	0.011	CbGeAlD
Etodolac—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000193	0.0106	CbGeAlD
Etodolac—PTGS1—brain—acquired immunodeficiency syndrome	0.00016	0.00878	CbGeAlD
Etodolac—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000155	0.00848	CbGeAlD
Etodolac—PTGS2—brain—acquired immunodeficiency syndrome	0.000153	0.00839	CbGeAlD
Etodolac—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000148	0.00811	CbGeAlD
Etodolac—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000604	CcSEcCtD
Etodolac—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000603	CcSEcCtD
Etodolac—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000602	CcSEcCtD
Etodolac—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000602	CcSEcCtD
Etodolac—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000601	CcSEcCtD
Etodolac—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000601	CcSEcCtD
Etodolac—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.0006	CcSEcCtD
Etodolac—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.000599	CcSEcCtD
Etodolac—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00012	0.000598	CcSEcCtD
Etodolac—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00012	0.000597	CcSEcCtD
Etodolac—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000597	CcSEcCtD
Etodolac—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000596	CcSEcCtD
Etodolac—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000596	CcSEcCtD
Etodolac—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000595	CcSEcCtD
Etodolac—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000595	CcSEcCtD
Etodolac—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000593	CcSEcCtD
Etodolac—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000593	CcSEcCtD
Etodolac—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000593	CcSEcCtD
Etodolac—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000591	CcSEcCtD
Etodolac—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000118	0.000588	CcSEcCtD
Etodolac—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000588	CcSEcCtD
Etodolac—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000588	CcSEcCtD
Etodolac—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000588	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000587	CcSEcCtD
Etodolac—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000587	CcSEcCtD
Etodolac—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000584	CcSEcCtD
Etodolac—Pain—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000584	CcSEcCtD
Etodolac—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000583	CcSEcCtD
Etodolac—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000117	0.000583	CcSEcCtD
Etodolac—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000583	CcSEcCtD
Etodolac—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000582	CcSEcCtD
Etodolac—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000581	CcSEcCtD
Etodolac—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.00058	CcSEcCtD
Etodolac—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.00058	CcSEcCtD
Etodolac—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.000579	CcSEcCtD
Etodolac—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000579	CcSEcCtD
Etodolac—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000579	CcSEcCtD
Etodolac—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000116	0.000578	CcSEcCtD
Etodolac—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000116	0.000578	CcSEcCtD
Etodolac—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000577	CcSEcCtD
Etodolac—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000577	CcSEcCtD
Etodolac—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000576	CcSEcCtD
Etodolac—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000575	CcSEcCtD
Etodolac—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000575	CcSEcCtD
Etodolac—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000575	CcSEcCtD
Etodolac—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.000573	CcSEcCtD
Etodolac—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000573	CcSEcCtD
Etodolac—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000573	CcSEcCtD
Etodolac—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000571	CcSEcCtD
Etodolac—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000571	CcSEcCtD
Etodolac—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000569	CcSEcCtD
Etodolac—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000568	CcSEcCtD
Etodolac—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000566	CcSEcCtD
Etodolac—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000564	CcSEcCtD
Etodolac—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000562	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000562	CcSEcCtD
Etodolac—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000561	CcSEcCtD
Etodolac—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000561	CcSEcCtD
Etodolac—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00056	CcSEcCtD
Etodolac—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000112	0.00056	CcSEcCtD
Etodolac—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000559	CcSEcCtD
Etodolac—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000112	0.000558	CcSEcCtD
Etodolac—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000112	0.000558	CcSEcCtD
Etodolac—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000558	CcSEcCtD
Etodolac—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000557	CcSEcCtD
Etodolac—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000556	CcSEcCtD
Etodolac—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.000556	CcSEcCtD
Etodolac—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000556	CcSEcCtD
Etodolac—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000554	CcSEcCtD
Etodolac—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000554	CcSEcCtD
Etodolac—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000552	CcSEcCtD
Etodolac—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000551	CcSEcCtD
Etodolac—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000551	CcSEcCtD
Etodolac—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000111	0.000551	CcSEcCtD
Etodolac—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.000551	CcSEcCtD
Etodolac—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.00055	CcSEcCtD
Etodolac—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00011	0.00055	CcSEcCtD
Etodolac—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000549	CcSEcCtD
Etodolac—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000548	CcSEcCtD
Etodolac—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.000548	CcSEcCtD
Etodolac—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000546	CcSEcCtD
Etodolac—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000546	CcSEcCtD
Etodolac—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000546	CcSEcCtD
Etodolac—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000545	CcSEcCtD
Etodolac—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000544	CcSEcCtD
Etodolac—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000543	CcSEcCtD
Etodolac—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000109	0.000542	CcSEcCtD
Etodolac—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00054	CcSEcCtD
Etodolac—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00054	CcSEcCtD
Etodolac—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000108	0.00054	CcSEcCtD
Etodolac—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000108	0.00054	CcSEcCtD
Etodolac—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000108	0.000538	CcSEcCtD
Etodolac—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000538	CcSEcCtD
Etodolac—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000108	0.000537	CcSEcCtD
Etodolac—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000536	CcSEcCtD
Etodolac—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000534	CcSEcCtD
Etodolac—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000534	CcSEcCtD
Etodolac—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000533	CcSEcCtD
Etodolac—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000533	CcSEcCtD
Etodolac—Rash—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000532	CcSEcCtD
Etodolac—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000532	CcSEcCtD
Etodolac—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000107	0.000532	CcSEcCtD
Etodolac—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000531	CcSEcCtD
Etodolac—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000531	CcSEcCtD
Etodolac—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000531	CcSEcCtD
Etodolac—Headache—Stavudine—acquired immunodeficiency syndrome	0.000106	0.000529	CcSEcCtD
Etodolac—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000106	0.000529	CcSEcCtD
Etodolac—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000528	CcSEcCtD
Etodolac—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000528	CcSEcCtD
Etodolac—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000528	CcSEcCtD
Etodolac—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000527	CcSEcCtD
Etodolac—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000527	CcSEcCtD
Etodolac—Rash—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000524	CcSEcCtD
Etodolac—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000524	CcSEcCtD
Etodolac—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000524	CcSEcCtD
Etodolac—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000524	CcSEcCtD
Etodolac—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000523	CcSEcCtD
Etodolac—Headache—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000521	CcSEcCtD
Etodolac—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00052	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.00052	CcSEcCtD
Etodolac—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000104	0.000519	CcSEcCtD
Etodolac—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000519	CcSEcCtD
Etodolac—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000516	CcSEcCtD
Etodolac—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000515	CcSEcCtD
Etodolac—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000513	CcSEcCtD
Etodolac—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000513	CcSEcCtD
Etodolac—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000512	CcSEcCtD
Etodolac—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000512	CcSEcCtD
Etodolac—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00051	CcSEcCtD
Etodolac—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00051	CcSEcCtD
Etodolac—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000509	CcSEcCtD
Etodolac—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000508	CcSEcCtD
Etodolac—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000507	CcSEcCtD
Etodolac—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000506	CcSEcCtD
Etodolac—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000505	CcSEcCtD
Etodolac—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000101	0.000503	CcSEcCtD
Etodolac—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000101	0.000503	CcSEcCtD
Etodolac—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000502	CcSEcCtD
Etodolac—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000502	CcSEcCtD
Etodolac—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000101	0.000502	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.0005	CcSEcCtD
Etodolac—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000499	CcSEcCtD
Etodolac—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.96e-05	0.000497	CcSEcCtD
Etodolac—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.94e-05	0.000496	CcSEcCtD
Etodolac—Nausea—Abacavir—acquired immunodeficiency syndrome	9.9e-05	0.000494	CcSEcCtD
Etodolac—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.88e-05	0.000493	CcSEcCtD
Etodolac—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.86e-05	0.000492	CcSEcCtD
Etodolac—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.82e-05	0.00049	CcSEcCtD
Etodolac—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.82e-05	0.00049	CcSEcCtD
Etodolac—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.81e-05	0.00049	CcSEcCtD
Etodolac—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.00049	CcSEcCtD
Etodolac—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.79e-05	0.000488	CcSEcCtD
Etodolac—Pain—Ritonavir—acquired immunodeficiency syndrome	9.78e-05	0.000488	CcSEcCtD
Etodolac—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.78e-05	0.000488	CcSEcCtD
Etodolac—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.78e-05	0.000488	CcSEcCtD
Etodolac—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.78e-05	0.000488	CcSEcCtD
Etodolac—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.73e-05	0.000485	CcSEcCtD
Etodolac—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.69e-05	0.000483	CcSEcCtD
Etodolac—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.68e-05	0.000483	CcSEcCtD
Etodolac—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.57e-05	0.000477	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.57e-05	0.000477	CcSEcCtD
Etodolac—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.52e-05	0.000475	CcSEcCtD
Etodolac—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.5e-05	0.000474	CcSEcCtD
Etodolac—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.49e-05	0.000473	CcSEcCtD
Etodolac—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.43e-05	0.00047	CcSEcCtD
Etodolac—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.42e-05	0.00047	CcSEcCtD
Etodolac—Pain—Saquinavir—acquired immunodeficiency syndrome	9.41e-05	0.00047	CcSEcCtD
Etodolac—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.41e-05	0.00047	CcSEcCtD
Etodolac—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.36e-05	0.000467	CcSEcCtD
Etodolac—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.36e-05	0.000467	CcSEcCtD
Etodolac—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.35e-05	0.000467	CcSEcCtD
Etodolac—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.35e-05	0.000467	CcSEcCtD
Etodolac—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.34e-05	0.000466	CcSEcCtD
Etodolac—Rash—Zidovudine—acquired immunodeficiency syndrome	9.28e-05	0.000463	CcSEcCtD
Etodolac—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.000463	CcSEcCtD
Etodolac—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.27e-05	0.000462	CcSEcCtD
Etodolac—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.24e-05	0.000461	CcSEcCtD
Etodolac—Headache—Zidovudine—acquired immunodeficiency syndrome	9.22e-05	0.00046	CcSEcCtD
Etodolac—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.14e-05	0.000456	CcSEcCtD
Etodolac—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.13e-05	0.000455	CcSEcCtD
Etodolac—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.11e-05	0.000455	CcSEcCtD
Etodolac—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.09e-05	0.000453	CcSEcCtD
Etodolac—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.07e-05	0.000453	CcSEcCtD
Etodolac—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.05e-05	0.000452	CcSEcCtD
Etodolac—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.05e-05	0.000451	CcSEcCtD
Etodolac—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.04e-05	0.000451	CcSEcCtD
Etodolac—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.04e-05	0.000451	CcSEcCtD
Etodolac—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9e-05	0.000449	CcSEcCtD
Etodolac—Pain—Lamivudine—acquired immunodeficiency syndrome	8.98e-05	0.000448	CcSEcCtD
Etodolac—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.98e-05	0.000448	CcSEcCtD
Etodolac—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000443	CcSEcCtD
Etodolac—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.84e-05	0.000441	CcSEcCtD
Etodolac—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.75e-05	0.000437	CcSEcCtD
Etodolac—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.000436	CcSEcCtD
Etodolac—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.74e-05	0.000436	CcSEcCtD
Etodolac—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.7e-05	0.000434	CcSEcCtD
Etodolac—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.7e-05	0.000434	CcSEcCtD
Etodolac—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.7e-05	0.000434	CcSEcCtD
Etodolac—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.65e-05	0.000432	CcSEcCtD
Etodolac—Rash—Indinavir—acquired immunodeficiency syndrome	8.63e-05	0.00043	CcSEcCtD
Etodolac—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.62e-05	0.00043	CcSEcCtD
Etodolac—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.59e-05	0.000428	CcSEcCtD
Etodolac—Headache—Indinavir—acquired immunodeficiency syndrome	8.57e-05	0.000428	CcSEcCtD
Etodolac—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.55e-05	0.000426	CcSEcCtD
Etodolac—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.46e-05	0.000422	CcSEcCtD
Etodolac—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.43e-05	0.00042	CcSEcCtD
Etodolac—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000416	CcSEcCtD
Etodolac—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.3e-05	0.000414	CcSEcCtD
Etodolac—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.3e-05	0.000414	CcSEcCtD
Etodolac—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.22e-05	0.00041	CcSEcCtD
Etodolac—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.21e-05	0.000409	CcSEcCtD
Etodolac—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.18e-05	0.000408	CcSEcCtD
Etodolac—Rash—Efavirenz—acquired immunodeficiency syndrome	8.15e-05	0.000407	CcSEcCtD
Etodolac—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.14e-05	0.000406	CcSEcCtD
Etodolac—Nausea—Indinavir—acquired immunodeficiency syndrome	8.13e-05	0.000405	CcSEcCtD
Etodolac—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.11e-05	0.000405	CcSEcCtD
Etodolac—Headache—Efavirenz—acquired immunodeficiency syndrome	8.1e-05	0.000404	CcSEcCtD
Etodolac—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.09e-05	0.000404	CcSEcCtD
Etodolac—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.9e-05	0.000394	CcSEcCtD
Etodolac—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.86e-05	0.000392	CcSEcCtD
Etodolac—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.82e-05	0.00039	CcSEcCtD
Etodolac—Rash—Delavirdine—acquired immunodeficiency syndrome	7.8e-05	0.000389	CcSEcCtD
Etodolac—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.79e-05	0.000389	CcSEcCtD
Etodolac—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.79e-05	0.000389	CcSEcCtD
Etodolac—Headache—Delavirdine—acquired immunodeficiency syndrome	7.75e-05	0.000387	CcSEcCtD
Etodolac—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.74e-05	0.000386	CcSEcCtD
Etodolac—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.68e-05	0.000383	CcSEcCtD
Etodolac—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.56e-05	0.000377	CcSEcCtD
Etodolac—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000376	CcSEcCtD
Etodolac—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.000376	CcSEcCtD
Etodolac—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.43e-05	0.000371	CcSEcCtD
Etodolac—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.35e-05	0.000366	CcSEcCtD
Etodolac—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.28e-05	0.000363	CcSEcCtD
Etodolac—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.27e-05	0.000363	CcSEcCtD
Etodolac—Rash—Ritonavir—acquired immunodeficiency syndrome	7.21e-05	0.00036	CcSEcCtD
Etodolac—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.2e-05	0.000359	CcSEcCtD
Etodolac—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.000358	CcSEcCtD
Etodolac—Headache—Ritonavir—acquired immunodeficiency syndrome	7.16e-05	0.000357	CcSEcCtD
Etodolac—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7e-05	0.000349	CcSEcCtD
Etodolac—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.94e-05	0.000346	CcSEcCtD
Etodolac—Rash—Saquinavir—acquired immunodeficiency syndrome	6.94e-05	0.000346	CcSEcCtD
Etodolac—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.93e-05	0.000346	CcSEcCtD
Etodolac—Headache—Saquinavir—acquired immunodeficiency syndrome	6.9e-05	0.000344	CcSEcCtD
Etodolac—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.79e-05	0.000339	CcSEcCtD
Etodolac—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.68e-05	0.000333	CcSEcCtD
Etodolac—Rash—Lamivudine—acquired immunodeficiency syndrome	6.62e-05	0.00033	CcSEcCtD
Etodolac—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.61e-05	0.00033	CcSEcCtD
Etodolac—Headache—Lamivudine—acquired immunodeficiency syndrome	6.58e-05	0.000328	CcSEcCtD
Etodolac—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.54e-05	0.000326	CcSEcCtD
Etodolac—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.24e-05	0.000311	CcSEcCtD
